EcoDrugPlus

Tissue Factor

Ensembl ID : ENSELUG00000023911
Gene Symbol: LOC105009168
2 Cross references
171 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSELUG00000008732
Gene Symbol: TLR2
3 Cross references
211 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSELUG00000016567
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSELUG00000005260
Gene Symbol: TLR8
1 Cross references
135 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSELUG00000016574
Gene Symbol: TLR8
4 Cross references
177 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSELUG00000000848
Gene Symbol: LOC106024755
3 Cross references
151 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1a

Ensembl ID : ENSELUG00000013696
Gene Symbol: TRPA1A
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSELUG00000007533
Gene Symbol: TRPA1B
1 Cross references
201 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSELUG00000000062
Gene Symbol: TTR
1 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSELUG00000021403
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSELUG00000012953
Gene Symbol: TUBA4A
3 Cross references
152 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSELUG00000001871
Gene Symbol: LOC105019718
3 Cross references
158 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).